SpaceX Investors Could Be in for a Rude Awakening, According to 1 Top Wall Street Analyst

Morningstar values SpaceX at $63 per share, about 70% below midday trading on June 16, 2026, and says the stock is "significantly overvalued." Even the firm’s most optimistic case is $154 per share, still about 28% below the current price, versus Oppenheimer’s bullish $190 target. The article highlights near-term dilution risk as private holders unlock, plus governance concerns from Elon Musk’s 82% voting control and potential acquisition-driven share issuance.

Analysis

The market is still pricing the IPO as a scarcity event rather than a cash-flow asset, which is why the first-order reaction can stay disconnected from fundamentals longer than most bears expect. The bigger issue is that the cap table is now a volatility machine: once lockup-style selling and employee monetization begin, the marginal buyer has to absorb a much larger free float without the “new issue” halo, which typically compresses multiple support fastest in the 1-3 month window.

The real competitive risk is not just a new satellite broadband rival; it is margin re-rating across the entire low-Earth-orbit stack. If a deep-pocketed entrant subsidizes terminal hardware and service pricing, SpaceX’s satellite business may still grow, but growth quality deteriorates as customers become more price-sensitive and financing needs rise. That dynamic matters because markets tend to punish the combination of slower ARPU expansion and higher reinvestment more than they reward unit growth.

Governance is the underappreciated catalyst because it creates an unhedgeable “decision risk” premium. With control so concentrated, investors are effectively underwriting optionality on future capital allocation, including M&A that could force dilution or saddle the business with integration risk; that is especially toxic in a narrative stock where holders assume every strategic move must be shareholder-friendly. The stock can remain elevated if sentiment stays AI-adjacent and index-eligible, but the setup is vulnerable to a sharp multiple reset once the market shifts from story to governance.

The contrarian angle is that the bearish case may be directionally right but timing-challenged: a tiny float and momentum flows can overpower valuation for weeks. Still, the asymmetry now favors downside because the upside requires near-flawless execution across launch cadence, AI data center commercialization, and competitive defense, while downside only needs one of those pillars to slip. That makes this more attractive as a structured short or relative-value expression than as an outright cash short into a melt-up.

Key Decisions for Investors

• Fade strength via a staged short into post-IPO liquidity expansion: initiate 25-50% of target size now, add on a 10-15% squeeze higher, with a 1-3 month horizon and thesis tied to float overhang and multiple compression.
• Express the view with a defined-risk put spread on SPCX rather than spot shorting: buy 3-6 month puts 20-30% out-of-the-money and sell lower strikes to finance, targeting 2:1 to 4:1 payoff if the stock rerates toward consensus-linked valuation bands.
• Pair trade: long AMZN / short SPCX for 2-4 months as a hedge against irrationally optimistic LEO pricing; the trade benefits if competitive subsidies or launch/terminal economics pressure SpaceX margins while the broader AI/infra complex stays bid.
• Avoid buying MORN on the headline despite the validation effect; the stock’s bearish call may be an important credibility event, but the market can discount the signal if SpaceX continues to rally. Better to wait for evidence of monetization and governance friction before positioning in MORN.
• If available, sell covered calls against any inherited SPCX exposure into elevated implied volatility; the risk/reward is poor for upside at current levels, and vol likely stays rich until the first meaningful secondary or insider sale window.